Published in J Virol on June 01, 1999
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 7.40
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature (1991) 6.79
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med (1985) 6.46
A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science (1988) 6.30
T cell activation determined by T cell receptor number and tunable thresholds. Science (1996) 5.51
Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad Sci U S A (1990) 5.35
Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol (1992) 5.05
Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science (1983) 4.72
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest (1989) 3.92
Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med (1996) 3.86
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest (1988) 3.59
Sequence and expression of transcripts of the human T-cell receptor beta-chain genes. Nature (1985) 3.53
Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line. Proc Natl Acad Sci U S A (1985) 3.41
Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J (1993) 3.13
The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell (1992) 3.11
Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science (1994) 3.10
Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol (1992) 3.06
Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain. Cell (1992) 2.69
Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly. J Cell Biol (1989) 2.65
CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol (1996) 2.61
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science (1989) 2.44
Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci U S A (1991) 2.38
LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science (1991) 2.37
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol (1986) 2.31
Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J (1997) 2.27
Primary structure of the T3 gamma subunit of the T3/T cell antigen receptor complex deduced from cDNA sequences: evolution of the T3 gamma and delta subunits. EMBO J (1986) 2.25
Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med (1993) 2.17
Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc Natl Acad Sci U S A (1985) 2.10
Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. Proc Natl Acad Sci U S A (1988) 2.07
Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex. Proc Natl Acad Sci U S A (1988) 1.95
Isolation and characterization of a cDNA clone encoding the murine homologue of the human 20K T3/T-cell receptor glycoprotein. Nature (1985) 1.92
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science (1986) 1.91
West African HIV-2-related human retrovirus with attenuated cytopathicity. Science (1988) 1.86
Endocytosis and recycling of the T3-T cell receptor complex. The role of T3 phosphorylation. J Exp Med (1987) 1.80
Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol (1993) 1.77
The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. J Virol (1994) 1.60
CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J (1994) 1.54
Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology (1994) 1.50
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc Natl Acad Sci U S A (1989) 1.48
A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J Virol (1992) 1.38
Differential regulation of human immunodeficiency viruses (HIVs): a specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor. Proc Natl Acad Sci U S A (1990) 1.37
The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages. EMBO J (1998) 1.33
Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex. Proc Natl Acad Sci U S A (1990) 1.33
Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol (1991) 1.32
Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells. Immunity (1995) 1.19
Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol (1993) 1.18
Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements. J Virol (1992) 1.17
The T cell antigen receptor alpha and beta chains interact via distinct regions with CD3 chains. Eur J Immunol (1994) 1.14
TCR alpha-CD3 delta epsilon association is the initial step in alpha beta dimer formation in murine T cells and is limiting in immature CD4+ CD8+ thymocytes. Immunity (1995) 1.11
Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals. J Immunol (1990) 1.07
Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals. J Virol (1993) 1.05
Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor. N Engl J Med (1992) 1.04
Failure to synthesize the CD3-gamma chain. Consequences for T cell antigen receptor assembly, processing, and expression. J Immunol (1992) 1.04
Association of phosphorylation of the T3 antigen with immune activation of T lymphocytes. Nature (1987) 1.04
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest (1996) 1.02
Distinct domains of the CD3-gamma chain are involved in surface expression and function of the T cell antigen receptor. J Biol Chem (1995) 1.02
Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J Immunol (1992) 1.02
Role of CD3 gamma in T cell receptor assembly. J Cell Biol (1996) 1.01
Specific decrease in T3 antigen density in adult T-cell leukaemia cells: I. Flow microfluorometric analysis. Br J Cancer (1984) 0.99
Role of CD3 delta in surface expression of the TCR/CD3 complex and in activation for killing analyzed with a CD3 delta-negative cytotoxic T lymphocyte variant. J Immunol (1992) 0.93
T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step. Eur J Immunol (1991) 0.93
A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci U S A (1990) 0.90
HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Defic Syndr (1994) 0.89
Molecular characterization of the di-leucine-based internalization motif of the T cell receptor. J Biol Chem (1996) 0.88
Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes. J Immunol (1990) 0.88
Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry. Am J Clin Pathol (1997) 0.87
Effects of HIV-1 Tat protein on human T cell proliferation. Eur J Immunol (1992) 0.86
T lymphocyte signalling defects and immunodeficiency due to the lack of CD3 gamma. Immunodeficiency (1993) 0.85
T3 surface molecules on adult T cell leukemia cells are modulated in vivo. Blood (1986) 0.84
Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy. Immunology (1992) 0.81
The T-cell antigen receptor: a multisubunit signaling complex. Chem Immunol (1994) 0.81
Evidence that a kinase distinct from protein kinase C induces CD3 gamma-subunit phosphorylation without a concomitant down-regulation in CD3 antigen expression. J Immunol (1989) 0.81
HIV glycoprotein gp120 inhibits TCR-CD3-mediated activation of fyn and lck. Int Immunol (1997) 0.80
Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. J Immunol (1993) 0.80
Selective disbalances of peripheral blood T lymphocyte subsets in human CD3 gamma deficiency. Eur J Immunol (1993) 0.79
Discordant gene and surface expression of the T-cell receptor/CD3 complex in adult T-cell leukemia cells. Cancer Res (1991) 0.78
Modulation of CD3-gamma gene expression after HIV type 1 infection of the WE17/10 T cell line is progressive and occurs in concert with decreased production of viral p24 antigen. AIDS Res Hum Retroviruses (1996) 0.77
Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation. J Immunol (1997) 0.76
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol (2007) 5.68
Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 3.06
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01
The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98
Class IIa histone deacetylases: regulating the regulators. Oncogene (2007) 1.78
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species. J Clin Microbiol (2010) 1.69
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect (2006) 1.65
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J Virol (1981) 1.58
Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58
Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J Clin Microbiol (1995) 1.55
Identification of Corynebacterium amycolatum and other nonlipophilic fermentative corynebacteria of human origin. J Clin Microbiol (1998) 1.53
Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res (1980) 1.53
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51
Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry (1999) 1.49
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
[Injuries missed in diagnosing severely injured accident victims in the emergency room]. Ned Tijdschr Geneeskd (1999) 1.42
Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo. Eur J Biochem (1975) 1.40
Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains. J Virol (1977) 1.39
Bovine leukemia virus, an animal model for the study of intrastrain variability. J Virol (1993) 1.38
Translational stability of native and deadenylylated rabbit globin mRNA injected into HeLa cells. Proc Natl Acad Sci U S A (1981) 1.35
Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci U S A (1994) 1.31
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv (1987) 1.29
Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol (1990) 1.29
Functional stabilisation of HeLa cell histone messenger RNAs injected into Xenopus oocytes by 3'-OH polyadenylation. Nature (1978) 1.26
In vivo transfection of bovine leukemia provirus into sheep. Virology (1992) 1.25
Humoral antibody response to bovine leukemia virus infection in cattle and sheep. Cancer Res (1979) 1.24
Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J Virol (1981) 1.24
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol (1988) 1.23
Semisolid selective-motility enrichment medium for isolation of salmonellae from fecal specimens. J Clin Microbiol (1984) 1.23
Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23
Goat lymphosarcoma from bovine leukemia virus. J Natl Cancer Inst (1981) 1.22
Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc Natl Acad Sci U S A (1988) 1.19
The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J Virol (1995) 1.18
Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob Agents Chemother (1995) 1.18
Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses (2000) 1.16
Chromosome integration domain for bovine leukemia provirus in tumors. J Virol (1983) 1.16
Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci U S A (1992) 1.16
A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat. J Virol (1992) 1.15
Bovine leukemia virus. Curr Top Microbiol Immunol (1984) 1.15
In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J Virol (1998) 1.14
Brevibacterium paucivorans sp. nov., from human clinical specimens. Int J Syst Evol Microbiol (2001) 1.14
A multidisciplinary selection model for youth soccer: the Ghent Youth Soccer Project. Br J Sports Med (2006) 1.13
Role of the 3' long open reading frame region of bovine leukemia virus in the maintenance of cell transformation. J Virol (1985) 1.13
New enrichment method for isolation of pathogenic Yersinia enterocolitica serogroup O:3 from pork. Appl Environ Microbiol (1988) 1.12
Bovine leukemia virus involvement in enzootic bovine leukosis. Adv Cancer Res (1978) 1.12
Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol (1997) 1.11
Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. Diagn Microbiol Infect Dis (1998) 1.09
The 3' region of bovine leukemia virus genome encodes a trans-activator protein. EMBO J (1986) 1.08
Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA. Proc Natl Acad Sci U S A (1977) 1.08
Involvement of the cyclic AMP-responsive element binding protein in bovine leukemia virus expression in vivo. J Virol (1994) 1.07
Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51. Virology (1989) 1.06
The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA. J Virol (1985) 1.06
Identification of Arthrobacter oxydans, Arthrobacter luteolus sp. nov., and Arthrobacter albus sp. nov., isolated from human clinical specimens. J Clin Microbiol (2000) 1.04
Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential. Proc Natl Acad Sci U S A (1992) 1.04
Anthropometric characteristics of elite male junior rowers. Br J Sports Med (2000) 1.04
Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J Virol (2001) 1.03
Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability. Virology (1984) 1.03
Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J Virol (2002) 1.02
Different bovine leukemia virus-induced tumors harbor the provirus in different chromosomes. J Virol (1984) 1.02
Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer. Adv Vet Sci Comp Med (1988) 1.00
A calcium/calmodulin-binding serine/threonine protein kinase homologous to the mammalian type II calcium/calmodulin-dependent protein kinase is expressed in plant cells. Plant Physiol (1993) 1.00
Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences. J Virol (1984) 1.00
Translational stability of plant viral RNAs microinjected into living cells. Influence of a 3'-poly(A) segment. Eur J Biochem (1983) 0.99
The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression. J Virol (1996) 0.99
The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo. J Gen Virol (1997) 0.98
[Patients without referral treated in the emergency room: patient characteristics and motives]. Ned Tijdschr Geneeskd (2000) 0.97
Chronic osteomyelitis due to Actinomyces neuii subspecies neuii and Dermabacter hominis. Eur J Clin Microbiol Infect Dis (2002) 0.97
In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene. J Virol (1999) 0.97
Peritonitis due to Brevibacterium otitidis in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (2000) 0.97
Cellular pathways involved in the ex vivo expression of bovine leukemia virus. J Virol (1996) 0.96
Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element. J Biol Chem (1999) 0.95
The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6. Oncogene (2011) 0.94
Differences in mouse mammary tumor viruses. Relationship to early and late occurring mammary tumors. Cancer (1977) 0.93
Measles outbreak in a refugee settlement in Calais, France: January to February 2016. Euro Surveill (2016) 0.93
Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation. Oncogene (1998) 0.93
Infection of rats with bovine leukaemia virus: establishment of a virus-producing rat cell line. J Gen Virol (1989) 0.92
Developmental and circadian pattern of rubisco activase mRNA accumulation in apple plants. Plant Mol Biol (1993) 0.92
The amino acid (157-197) peptide segment of bovine leukemia virus p34tax encompass a leucine-rich globally neutral activation domain. Oncogene (1991) 0.92
Structural and functional characterization of mutants of the bovine leukemia virus transactivator protein p34. Virology (1989) 0.91
Expression of a cDNA clone corresponding to the long open reading frame (XBL-I) of the bovine leukemia virus. Virology (1987) 0.91
Corynebacterium simulans sp. nov., a non-lipophilic, fermentative Corynebacterium. Int J Syst Evol Microbiol (2000) 0.91
Anthropometric characteristics of elite female junior rowers. J Sports Sci (2001) 0.90